Lars Damstrup

2.7k total citations
43 papers, 1.9k citations indexed

About

Lars Damstrup is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Lars Damstrup has authored 43 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 19 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Lars Damstrup's work include HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Lung Cancer Treatments and Mutations (7 papers). Lars Damstrup is often cited by papers focused on HER2/EGFR in Cancer Research (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers) and Lung Cancer Treatments and Mutations (7 papers). Lars Damstrup collaborates with scholars based in Denmark, United States and Germany. Lars Damstrup's co-authors include Hans Skovgaard Poulsen, Mogens Spang‐Thomsen, Björn G. Voldborg, Mikkel W. Pedersen, Robert J. Coffey, Raymond N. DuBois, Ramona Graves‐Deal, Peter J. Dempsey, C J Hawkey and K Rygaard and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

Lars Damstrup

43 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Damstrup Denmark	19	910	902	452	233	226	43	1.9k
Cordula Petersen Germany	26	870 1.0×	1.0k 1.2×	435 1.0×	291 1.2×	493 2.2×	60	2.0k
Bianca Maria Veneziani Italy	22	821 0.9×	1.0k 1.1×	689 1.5×	97 0.4×	338 1.5×	51	2.0k
Luka Milas United States	19	643 0.7×	489 0.5×	376 0.8×	138 0.6×	257 1.1×	41	1.4k
Mohit Trikha United States	29	930 1.0×	1.2k 1.3×	227 0.5×	134 0.6×	384 1.7×	55	2.5k
B. Helfrich United States	13	726 0.8×	698 0.8×	581 1.3×	90 0.4×	294 1.3×	27	1.4k
Peter Shintaku United States	19	630 0.7×	1.0k 1.1×	190 0.4×	191 0.8×	553 2.4×	30	1.9k
Ivan Ding United States	23	388 0.4×	698 0.8×	343 0.8×	105 0.5×	366 1.6×	45	1.7k
R. Lotan United States	18	561 0.6×	1.7k 1.9×	429 0.9×	128 0.5×	371 1.6×	30	2.7k
Vincenzo Damiano Italy	26	1.9k 2.1×	1.4k 1.5×	1.2k 2.5×	135 0.6×	459 2.0×	62	3.2k
Thomas Bogenrieder Germany	25	1.2k 1.3×	1.2k 1.3×	342 0.8×	96 0.4×	536 2.4×	63	2.6k

Countries citing papers authored by Lars Damstrup

Since Specialization

Citations

This map shows the geographic impact of Lars Damstrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Damstrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Damstrup more than expected).

Fields of papers citing papers by Lars Damstrup

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Damstrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Damstrup. The network helps show where Lars Damstrup may publish in the future.

Co-authorship network of co-authors of Lars Damstrup

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Damstrup. A scholar is included among the top collaborators of Lars Damstrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Damstrup. Lars Damstrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bourhis, Jean, C. Le Tourneau, Y. Pointreau, et al.. (2022). LBA33 5-year overall survival (OS) in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant + chemoradiotherapy (CRT) vs placebo + CRT in a randomized, phase II study. Annals of Oncology. 33. S1400–S1400. 6 indexed citations

Bussel, Mark T. J. van, Ahmad Awada, Maja J.A. de Jonge, et al.. (2020). A first-in-man phase 1 study of the DNA-dependent protein kinase inhibitor peposertib (formerly M3814) in patients with advanced solid tumours. British Journal of Cancer. 124(4). 728–735. 75 indexed citations

Cutsem, Eric Van, Manuel Hidalgo, I. Bazin, et al.. (2015). Phase II randomized trial of MEK inhibitor pimasertib or placebo combined with gemcitabine in the first-line treatment of metastatic pancreatic cancer.. Journal of Clinical Oncology. 33(3_suppl). 344–344. 19 indexed citations

Dizon, Don S., Lars Damstrup, Neil J. Finkler, et al.. (2012). Phase II Activity of Belinostat (PXD-101), Carboplatin, and Paclitaxel in Women With Previously Treated Ovarian Cancer. International Journal of Gynecological Cancer. 22(6). 979–986. 66 indexed citations

Sørensen, Jens Benn, et al.. (2008). Double‐blind, placebo‐controlled, randomized study of chlorhexidine prophylaxis for 5‐fluorouracil‐based chemotherapy‐induced oral mucositis with nonblinded randomized comparison to oral cooling (cryotherapy) in gastrointestinal malignancies. Cancer. 112(7). 1600–1606. 67 indexed citations

Pedersen, Mikkel W., Nina Marie Pedersen, Lars Damstrup, et al.. (2005). Analysis of the epidermal growth factor receptor specific transcriptome: Effect of receptor expression level and an activating mutation. Journal of Cellular Biochemistry. 96(2). 412–427. 42 indexed citations

Damstrup, Lars, Mikkel W. Pedersen, Lone Bastholm, Folmer Elling, & Hans Skovgaard Poulsen. (2001). Epidermal growth factor receptor mutation type iii transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype. International Journal of Cancer. 97(1). 7–14. 32 indexed citations

Pedersen, Mikkel W., et al.. (2001). The type III epidermal growth factor receptor mutation. Annals of Oncology. 12(6). 745–760. 200 indexed citations

Pedersen, Mikkel W., Thomas Thykjær, Torben F. Ørntoft, Lars Damstrup, & Hans Skovgaard Poulsen. (2001). Profile of differentially expressed genes mediated by the type III epidermal growth factor receptor mutation expressed in a small-cell lung cancer cell line. British Journal of Cancer. 85(8). 1211–1218. 18 indexed citations

10.

Kuwada, Scott K., et al.. (1999). The Dynamic Expression of the Epidermal Growth Factor Receptor and Epidermal Growth Factor Ligand Family in a Differentiating Intestinal Epithelial Cell Line. Growth Factors. 17(2). 139–153. 16 indexed citations

11.

Damstrup, Lars, Scott K. Kuwada, Peter J. Dempsey, et al.. (1999). Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis. British Journal of Cancer. 80(7). 1012–1019. 57 indexed citations

12.

Nørgaard, Peter, et al.. (1998). High value of the radiobiological parameter Dq correlates to expression of the transforming growth factor β type II receptor in a panel of small cell lung cancer cell lines. Lung Cancer. 20(1). 65–69. 3 indexed citations

13.

Voldborg, Björn G., Lars Damstrup, Mogens Spang‐Thomsen, & Hans Skovgaard Poulsen. (1997). Epidermal growth factor receptor (EGFR) and EGFR mutations, function and possible role in clinical trials. Annals of Oncology. 8(12). 1197–1206. 402 indexed citations

14.

Nørgaard, Peter, et al.. (1996). Acquired TGFβ1 sensitivity and TGFβ1 expression in cell lines established from a single small cell lung cancer patient during clinical progression. Lung Cancer. 14(1). 63–73. 2 indexed citations

15.

Gangarosa, Lisa M., Peter J. Dempsey, Lars Damstrup, John Barnard, & Robert J. Coffey. (1996). Transforming growth factor-α. Baillière s Clinical Gastroenterology. 10(1). 49–63. 21 indexed citations

16.

Coffey, Robert J., Lisa M. Gangarosa, Lars Damstrup, & Peter J. Dempsey. (1995). Basic actions of transforming growth factor-?? and related peptides. European Journal of Gastroenterology & Hepatology. 7(10). 923–927. 14 indexed citations

17.

Damstrup, Lars & Hans Skovgaard Poulsen. (1994). Review of the curative role of radiotherapy in the treatment of non-small cell lung cancer. Lung Cancer. 11(3-4). 153–178. 30 indexed citations

18.

Nørgaard, Peter, Lars Damstrup, K Rygaard, Mogens Spang‐Thomsen, & Hemming Poulsen. (1994). Growth suppression by transforming growth factor β1 of human small-cell lung cancer cell lines is associated with expression of the type II receptor. British Journal of Cancer. 69(5). 802–808. 41 indexed citations

19.

Damstrup, Lars, J. Andersen, Donald Küfe, Daniel F. Hayes, & Hans Skovgaard Poulsen. (1992). Immunocytochemical determination of the estrogen-regulated proteins Mr 24, 000, Mr 52, 000 and DF3 breast cancer associated antigen: Clinical value in advanced breast cancer and correlation with estrogen receptor. Annals of Oncology. 3(1). 71–77. 14 indexed citations

20.

Damstrup, Lars, Gedske Daugaard, Jan Gerstoft, & Mikael Rørth. (1989). Effects of antineoplastic treatment of HIV-positive patients with testicular cancer. European Journal of Cancer and Clinical Oncology. 25(6). 983–986. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact